Heart device study in india aims to track AF progression

NCT ID NCT04172883

Terminated Knowledge-focused Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how Medtronic heart devices detect and manage atrial fibrillation (AF) in Indian patients. It tracked whether the condition became persistent over time. The study enrolled 79 people over 55 with heart devices. It was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES

Contacts and locations

Locations

AIG hospital

Hyderabad, Telangana, India
Apollo BGS Hospital

Mysore, Karnataka, India
Apollo Hospital

Bhubaneswar, Odisha, India
Apollo Hospital

Chennai, Tamil Nadu, India
Apollo Hospital , Bannerghatta

Bangalore, Karnataka, India
Aster Medicity

Kochi, Kerala, India
Care Institute of medical sciences and research

Ahmedabad, Gujarat, India
Eternal Heart Care center and Research

Jaipur, Rajasthan, India
Fortis Escort Hospital

Mohali, Punjab, India
Fortis Escorts Heart Institute

New Delhi, National Capital Territory of Delhi, India
Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.